The results concluded that the nomogram constructed based on the expression of MTA2 and clinical characteristics of HCC can effectively predict the prognosis of HCC patients, and MTA2 can be regarded as a useful indicator to determine the prognosis of HCC patients for the clinical therapy of HCC. Here, MTA2 is linked to hepatocellular carcinoma.